Breast cancer-related fatigue. Neoplastic (malignant) related fatigue
Conditions
Interventions
Intervention 1: Intervention group: Each violet tablet contains 500 mg of aqueous extract of Viola odorata and one tablet is taken every 12 hours for 4 weeks. Intervention 2: Control group: The placeb
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: 25 - 65 years old women Breast Cancer Patients Radiation Treatment in Progress Fatigue Score above 37 based on FSS questionnaire Hemoglobin at least 10 g/dl Hematocrit at least 30% SGOT less than 3 folds of normal limit Bilirubin less than 2 mg/dl Creatinine less than 2 mg/dl Normal TSH
Exclusion criteria
Exclusion criteria: Bilateral breast involvement History of asthma Uncontrolled pain History of severe heart disease History of allergy to violet
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of Fatigue Severity "Visual Analogue Fatigue Scale". Timepoint: The beginning of the study and 4 weeks later. Method of measurement: Using Visual Analogue Fatigue Scale questionnaire.;Score of "Fatigue Severity". Timepoint: The beginning of the study and 4 weeks later. Method of measurement: Fatigue Severity Scale questionnaire.;Score of "The Cancer Fatigue Scale". Timepoint: The beginning of the study and 4 weeks later. Method of measurement: The Cancer Fatigue Scale questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Score of "Quality of life". Timepoint: The beginning of the study and 4 weeks later. Method of measurement: Quality of life questionnaire.;Score of "Treatment Satisfaction". Timepoint: After the Intervention completion. Method of measurement: Treatment Satisfaction questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Khancherli
Shahid Beheshti University of Medical Sciences
Outcome results
None listed